Edition:
United Kingdom

Aratana Therapeutics Inc (PETX.OQ)

PETX.OQ on NASDAQ Stock Exchange Global Market

5.36USD
19 Oct 2018
Change (% chg)

$-0.04 (-0.74%)
Prev Close
$5.40
Open
$5.38
Day's High
$5.55
Day's Low
$5.28
Volume
67,513
Avg. Vol
70,167
52-wk High
$7.28
52-wk Low
$3.68

Chart for

About

Aratana Therapeutics, Inc. is a pet therapeutics company focused on licensing, developing and commercializing of biopharmaceutical products for companion animals. The Company's portfolio includes therapeutic candidates in development consisting of small molecule pharmaceuticals and large molecule biologics that target medical... (more)

Overall

Beta: 3.45
Market Cap(Mil.): $273.92
Shares Outstanding(Mil.): 43.00
Dividend: --
Yield (%): --

Financials

  PETX.OQ Industry Sector
P/E (TTM): -- 30.90 33.64
EPS (TTM): -1.62 -- --
ROI: -43.08 14.75 14.27
ROE: -56.94 16.24 15.99

BRIEF-Aratana Therapeutics Q1 Loss Per Share $0.19

* ARATANA THERAPEUTICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

03 May 2018

Competitors

  Price Chg
Novartis AG (NOVN.S) CHF87.04 +1.16
Merck & Co., Inc. (MRK.N) $72.35 +0.14
Bayer AG (BAYGn.DE) €77.59 -0.83
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €77.80 0.00
Eli Lilly And Co (LLY.N) $111.92 -1.39
Zoetis Inc (ZTS.N) $91.47 -0.36
Virbac SA (VIRB.PA) €147.00 +0.40
Vetoquinol SA (VETO.PA) €51.20 0.00
Dechra Pharmaceuticals plc (DPH.L) 2,332.00 +172.00

Earnings vs. Estimates